SynAct Pharma AB insider transactionsStockholm

LEI 549300RRYIEFEQ72N546 · XSTO · SE · Business ID 559058-4826

Get alerts for SynAct Pharma AB

12-month buy/sell summary

SEK 532,364.22 boughtSEK 8,900,000.00 sold
Open-market buys: 8Sales: 2Share awards: 0

Recent insider sentiment

Net selling — last 90 days
No buysSEK 8,900,000.00 sold

Share-award batches are excluded from this read — they’re compensation, not conviction.

0
Open-market buys (90d)
2
Sales (90d)
0
Share awards (90d)
2
Active insiders (90d)

Transactions

DatePersonTransaction typeVolumePriceValueSource
02.09.2026
TJ Biotech Holding Aps
Closely associated with Thomas Jonassen
SoldDisposal
350,000SEK 17.80
SEK 6,230,000.00
↗
02.09.2026
Quantass ApS
Closely associated with Jeppe Øvlesen
SoldDisposal
150,000SEK 17.80
SEK 2,670,000.00
↗
10.03.2026✎
Anders Kronborg — Board member
Bought — open marketAcquisition
2,750SEK 18.12
SEK 49,830.00
↗
05.03.2026
Bought — open marketAcquisition
1,500SEK 17.92
SEK 26,880.00
↗
05.03.2026
Quantass ApS
Closely associated with Jeppe Øvli Øvlesen
Bought — open marketAcquisition
7,900SEK 17.99
SEK 142,145.58
↗
03.03.2026
Boesen Biotech ApS
Closely associated with Thomas Boesen
Bought — open marketAcquisition
2,750SEK 17.92
SEK 49,280.00
↗
03.03.2026
Boesen Biotech ApS
Closely associated with Thomas Boesen
Bought — open marketAcquisition
2,700SEK 17.90
SEK 48,330.00
↗
19.12.2025
TJ Biotech Holding Aps
Closely associated with Thomas Jonassen
Bought — open marketAcquisition
3,529SEK 20.45
SEK 72,168.05
↗
19.12.2025
Anders Kronborg — Board member
Bought — open marketAcquisition
3,470SEK 20.84
SEK 72,301.27
↗
17.12.2025
Quantass ApS — CEO
Bought — open marketAcquisition
3,529SEK 20.24
SEK 71,429.32
↗